Barclays’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Barclays’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,683	Closed	-$185K	–	5411
2024 Q1	$185K	Buy	+8,683	New	+$104K	﹤0.01%	4150

Barclays's FUSN Position: Q2 2024 in Review

Barclays sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 8,683 shares — an estimated $185K sold.

Barclays first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $185K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Barclays reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Barclays sold 8,683 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $185K.
Barclays first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Barclays's Fusion Pharmaceuticals Inc. Common Shares position peaked at $185K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.